Indian pharma excipients distributor IndChem acquired by Dutch firm IMCD

20 February 2013

Netherlands-based conglomerate IMCD Group BV has acquired the business of IndChem International, an established player in the pharmaceutical ingredients market in India. Financial terms of the transaction were not disclosed.

The Mumbai-based IndChem business has already been fully integrated into IMCD India and all key personnel have transferred to IMCD. IMCD said that this latest acquisition confirms that India is an important growth market for the Rotterdam-based speciality chemicals and food ingredients distributor. IMCD Business Group Pharmaceuticals is one of the leading pharmaceutical excipients players in the world.

“The two companies share a culture of having a focus to grow as a company that offers an entire range of excipients, thus providing a single stop solution for all their clients’ formulation needs,” comments Ashvin Patel, IMCD business director India, adding: “With IndChem’s excellent customer service and technical support on board, IMCD will be able to further strengthen our presence on the Indian market.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Generics